Is tiprolidine safe to use in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Tiprolidine is generally considered safe for patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency. There is no established contraindication or specific warning against using tiprolidine in G6PD-deficient patients. Tiprolidine is an antihistamine primarily used to treat allergic conditions and does not belong to the classes of medications known to trigger hemolytic anemia in G6PD deficiency. Unlike medications such as certain antimalarials, sulfonamides, nitrofurantoin, and some NSAIDs that can cause oxidative stress leading to hemolysis in G6PD-deficient individuals, tiprolidine works by blocking histamine receptors and does not typically generate oxidative metabolites that would stress red blood cells.

Key Points to Consider

  • A recent study 1 found that many medications previously thought to be risky for G6PD-deficient patients were actually prescribed safely, providing reassurance for patients and prescribers.
  • The study 1 identified only a few medications that were associated with hemolysis in G6PD-deficient patients, and tiprolidine was not one of them.
  • Another study 2 also found that there is no evidence to contravene the use of most medications, including tiprolidine, in G6PD-deficient patients.
  • However, as with any medication, individual responses can vary, and patients with G6PD deficiency should monitor for signs of hemolysis such as dark urine, fatigue, or jaundice when starting any new medication.
  • If such symptoms occur, they should seek medical attention immediately. Healthcare providers should still consider the patient's complete medical history and medication profile when prescribing tiprolidine.

Recommendations for Clinical Practice

  • Tiprolidine can be used in patients with G6PD deficiency, but with caution and monitoring for signs of hemolysis.
  • Healthcare providers should consider the patient's complete medical history and medication profile when prescribing tiprolidine.
  • Patients with G6PD deficiency should be educated on the signs of hemolysis and the importance of seeking medical attention if they occur.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.